The effect of estrogens and phytoestrogenic lignans on macrophage uptake of atherogenic lipoproteins

BioFactors

Volumn 20, Issue 3, 2004, Pages 119-127

  Owen, Alice J ^a,b,c   Abbey, Mavis ^b  

^a UNIVERSITY OF ADELAIDE   (Australia)

^b CSIRO   (Australia)

^c UNIVERSITY OF WOLLONGONG   (Australia)

Author keywords

estrogens; LDL; Lp(a); macrophage; phytoestrogens

Indexed keywords

ENTERODIOL; ENTEROLACTONE; ESTRADIOL; ESTROGEN; ESTRONE; LIGNAN DERIVATIVE; LINOLEIC ACID; LIPOPROTEIN; LIPOPROTEIN A; LOW DENSITY LIPOPROTEIN; PHYTOESTROGEN; TRITIUM;

ANIMAL CELL; ARTICLE; ATHEROSCLEROSIS; CELL TRANSPORT; CONTROLLED STUDY; ESTROGEN ACTIVITY; HORMONE ACTION; ISOTOPE LABELING; MACROPHAGE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN TRANSPORT;

EID: 12844253802     PISSN: 09516433     EISSN: None     Source Type: Journal    
DOI: 10.1002/biof.5520200301     Document Type: Article

References (49)

1. W.B. Kannel, T. Gordon and W.P. Castelli, Role of lipids and lipoprotein fractions in atherogenesis: the Framingham Study, Prog. Lipid Res. 20 (1981), 339-348.
2. J. Danesh, R. Collins and R. Peto, Lipoprotein(a) and coronary heart disease. Meta-analysis of prospective studies, Circulation 102 (2000), 1082-1085.
3. L. Berglund, Diet and drug therapy for lipoprotein(a), Curr. Opin. Lipid. 6 (1995), 48-56.
4. H.F. Hoff, J. O'Neil and A. Yashiro, Partial characterization of lipoproteins containing apo[a] in human atherosclerotic lesions, J. Lipid Res. 34 (1993), 789-798.
5. D. Steinberg, S. Parthasarathy, T.E. Carew, J.C. Khoo and J.L. Witztum, Beyond cholesterol: modifications of low density lipoprotein that increase its atherogenicity, N. Engl. J. Med. 320 (1989), 915-924.
6. Sulistiyani, S.J. Adelman, A. Chandrasekaran, J. Jayo and R.W. St Clair, Effect of 17β-dihydroequlin sulfate, a conjugated equine estrogen, and ethynylestradiol on atherosclerosis in cholesterol-fed rabbits, Arterioscler. Thromb. Vasc. Biol. 15 (1995), 837-846.
7. M.R. Adams, J.R. Kaplan, S.B. Manuck, D.R. Koritnik, J.S. Parks, M.S. Wolfe and T.B. Clarkson, Inhibition of coronary artery atherosclerosis by 17-beta estradiol in ovariectomized monkeys, Arteriosclerosis 10 (1990), 1051-1057.
8. E. Barrett-Connor and T.L. Bush, Estrogen and coronary heart disease in women, JAMA 265 (1991), 1861-1867.
9. D.M. Herrington, D.M. Reboussin, K.B. Brosnihan, P.C. Sharp, S.A. Shumaker, T.E. Snyder, C.D. Furberg, G.J. Kowalchuk, T.D. Stuckey, W.J. Rogers, D.H. Givens and D. Waters, Effects of estrogen replacement on the progression of coronary artery atherosclerosis, N. Eng. J. Med. 343 (2000), 522-529.
10. R.P. Byington, C.D. Furberg, D.M. Herrington, J.A. Herd, D. Hunninghake, M. Lowery, W. Riley, T. Craven, L. Chaput, C.C. Ireland and W.B. Applegate, Effect of estrogen plus progestin on progression of carotid atherosclerosis in postmenopausal women with heart disease, Arterioscler. Thromb. Vasc. Biol. 22 (2002), 1692-1697.
11. H.D. Nelson, E.E. Humphrey, P. Nygren, S.M. Teutsch and J.D. Allan, Postmenopausal hormone replacement therapy: scientific review, JAMA. 228 (2002), 872-881.
12. H.N. Hodis, W.J. Mack, R.A. Lobo, D. Shoupe, A. Sevanian, P.R. Mahrer, M.S. Selzer, C. Liu, C. Liu and S.P. Azen, Estrogen in the prevention of atherosclerosis, Ann. Intern. Med. 135 (2001), 939-953.
13. D.P. McDonnell and J.D. Norris, Connections and regulation of the human estrogen receptor, Science 296 (2002), 1642-1644.
14. E. Barrett-Connor, S. Slone, G. Greendale, D. Kritz-Silverstein, M. Espeland, S.R. Johnson, M. Waclawiw and S.E. Fineberg, The postmenopausal estrogen/progestin interventions study: primary outcomes in adherent women, Maturitas 27(1997), 261-274.
15. K. Prasad, S.V. Mantha, A.D. Muir and N.D. Westcott, Reduction of hypercholesterolemic atherosclerosis by CDC-flaxseed with very low alpha-linolenic acid, Atherosclerosis 136 (1998), 367-375.
16. S. Gulshan, A.B. McCruden and W.H. Stimson, Oestrogen receptors in macrophages, Scand. J. Immunol. 31 (1990), 691-697.
17. T. Tomita, F. Sawamura, R. Uetsuka, M. Ikeda and I. Tomita, The regulation of cholesteryl ester metabolism by 17b-estradiol in macrophages: activation of neutral cholesterol esterase, Ann. N. Y. Acad. Sci. 748 (1995), 637-639.
18. M. Lacort, A.M. Leal, M. Liza, C. Martin, R. Martinez and M.B. Ruiz-Larrea, Protective effect of estrogens and catecholestrogens against peroxidative membrane damage in vitro, Lipids 30 (1995), 141-146.
19. C.A. Rice-Evans, N.J. Miller and G. Paganga, Structure-Antioxidant activity relationships of flavonoids and phenolic acids, Free Rad. Biol. Med. 20 (1996), 933-956.
20. M. Suzukawa, M. Abbey, P. Clifton and P.J. Nestel, Effects of supplementing with vitamin E on the uptake of low density lipoprotein and the stimulation of cholesteryl ester formation in macrophages, Atherosclerosis 110 (1994), 77-86.
21. G.M. Fless and M.L. Snyder, Quantitation of lipoprotein(a) after lysine sepharose chromatography and density gradient centrifugation, Methods Enzymol 263 (1996), 238-251.
22. J.J. Albers, H. Kennedy and S.M. Marcovina, Evidence that Lp(a) contains on molecule of apo(a) and one molecule of apoB: evaluation of amino acid analysis data, J. Lipid Res. 37 (1996), 192-196.
23. O.H. Lowry, N.J. Rosenburg, A.L. Farr and R.J. Randall, Protein measurements with die folin phenol reagent, J. Biol. Chem. 193(1951), 265-275.
24. T. Mazzone, L. Pustelnikas and C.A. Reardon, Post-translational regulation of macrophage apoprotein E production, J. Biol. Chem. 267(1993), 1081-1087.
25. G.H. Dahlen, Lp(a) lipoprotein in cardiovascular disease, Atherosclerosis 108 (1994), 111-126.
26. J.L. Goldstein and M.S. Brown, Regulation of low-density lipoprotein receptors: implications for pathogenesis and therapy of hypercholesterolemia and atherosclerosis, Circulation 76 (1987), 504-507.
27. Y. Huang, M.J. Ghosh and M.F. Lopes-Virella, Transcriptional and post-translational regulation of LDL receptor gene expression in PMA-treated THP-1 cells by LDL-containing immune complexes, J. Lipid Res. 38 (1997), 110-120.
28. C.F. Semenkovich and R.E. Ostlund Jr., Estrogens induce low density lipoprotein receptor activity and decrease intracel-lular cholesterol in human hepatoma cell line HepG2, Biochemistry 26 (1987), 4987-4-992.
29. B. Angelin, H. Olivecrona, E. Reihnér, M. Rudling, D. Ståhlberg, M. Eriksson, S. Ewerth, P. Henriksson and K. Einarsson, Hepatic cholesterol metabolism in estrogen treated men, Gastroenterology 103 (1992), 1657-1663.
30. J.A. Cuthbert and P.E. Lipsky, Tissue-specific regulation of low density lipoprotein receptor gene expression, Trans. Assoc. Am. Physicians 103 (1990), 271-280.
31. V.W. Armstrong, B. Harrach, H. Robenek, M. Helmhold, A.K. Walli and D. Seidel, Heterogeneity of human lipoprotein Lp(a): cytochemical and biochemical studies on the interaction of two Lp(a) species with the LDL receptor, J. Lipid Res. 31 (1990), 429-441.
32. G.A. Keesler, Y. Li, P.J. Skiba, G.M. Fless and I. Tabas, Macrophage foam cell lipoprotein(a)/apoprotein(a) receptor: cell surface localization, dependence of induction on new protein synthesis, and ligand specificity, Arterioscler. Thromb. 14(1994), 1337-1345.
33. K. McTigue Argraves, K.F. Kozarsky, J.T. Fallon, P.C. Harpel and D.K. Strickland, The atherogenic lipoprotein Lp(a) is internalized and degraded in a process mediated by the VLDL receptor, J. Clin. Invest. 100 (1997), 2170-2181.
34. A. Hrzenjak, S. Frank, X. Wo, Y. Zhou, T. van Berkel, G.M. Kostner, Galactose specific asialoglycoprotein receptor is involved in lipoprotein(a) catabolism, Biochem. J. 376 (2003), 765-771.
35. M.E. Haberland, G.M. Fless, A.M. Scanu and A.M. Fogelman, Malondialdehyde modification of lipoprotein(a) produces avid uptake by human monocyte-macrophages, J. Biol. Chem. 267 (1992), 4143-4151.
36. M. Naruszewicz, E. Selinger and J. Davignon, Oxidative modification of lipoprotein(a) and the effect of beta-carotene, Metabolism 41 (1992), 1215-1224.
37. W. Sattler, G.M. Kostner, G. Waeg, H. Esterbauer, Oxidation of lipoprotein Lp(a). A comparison with low-density lipoproteins, Biochim. Biophys. Acta 1081 (1991), 65-74.
38. B. Karten, H. Boechzelt, P.M. Abuja, M. Mittelbach and W. Sattler, Macrophage-enhanced formation of cholesteryl ester-core aldehydes during oxidation of low density lipoprotein, J. Lipid Res. 40 (1999), 1240-1253.
39. F. Sigari, C. Lee, J.L. Witztum and P.D. Reaven, Fibroblasts that overexpress 15-lipoxygenase generate bioactive and minimally modified LDL, Arterioscler. Thromb. Vasc. Biol. 17 (1997), 3639-3645.
40. Sulistiyani and R.W. St Clair, Effect of 17/3-estradiol on metabolism of acetylated low-density lipoprotein by THP-I macrophages in culture, Arterioscler. Thromb. Vasc. Biol. 17 (1997), 1691-1700.
41. G.T. Shwaery, J.A. Vita and J.F. Keaney, Antioxidant protection of LDL by physiologic concentrations of estrogens is specific for 17-beta-estradiol, Atherosclerosis 138 (1998), 255-262.
42. J.A. McCrohon, S. Nakhla, W. Jessup, K.K. Stanley and D.S. Celermajer, Estrogen and progesterone reduce lipid accumulation in human monocyte derived macrophages: a sex specific effect, Circulation 100 (1999), 2319-2325.
43. J.A. Contreras and M.A. Lasuncion, Essential differences in cholesteryl ester metabolism between human monocyte-derived and J774 macrophages, Arterioscler. Thromb. 14 (1994), 443-452.
44. D.E. Leszcynski and R.M. Schafer, Characterisation of steroid hormone association with human plasma lipoproteins, Steroids 54 (1989), 1110-1114.
45. M.E. Martin, M. Haourigui, C. Pelisseo, C. Benassayag and E.A. Nunez, Interactions between phytoestrogens and human sex steroid binding protein, Life Sci 58 (1996), 429-436.
46. W.V. Welshons, C.S. Murphy, R. Koch, G. Calaf and V.C. Jordan, Stimulation of breast cancer cells in vitro by the environmental estrogen enterolactone and the phytoestrogen equol, Breast Cancer Res. Treat. 10 (1987), 167-175.
47. D.D. Jutts, Y.V. Yuan, A.N. Wijewickreme and L.U. Thompson, Antioxidant activity of the flaxseed lignan secoisolariciresinol diglycoside and its mammalian lignan metabolites enterodiol and enterolactone, Mol. Cell. Biochem. 202 (1999), 91-100.
48. A.J. Owen, P.D. Roach and M. Abbey, The regulation of low density lipoprotein receptor activity by estrogens and phytoestrogens in a HepG2 cell model, Ann. Nutr. Metab. 48 (2004), 269-275.
49. H. Adlercreutz, T. Fotsis, J. Lampe, K. Wähälä, T. Mäkelä, G. Brunow and T. Hase, Quantitative determination of lignans and isoflavonoids in plasma of omnivorous and vegetarian women by isotope dilution gas chromatography-mass spectrometry, Scand. J. Clin. Lab. Invest. Suppl. 215 (1993), 5-18.